Monday, March 25, 2019 9:26:00 AM
Did anyone ever tell you that you are quite cute when you get upset?
As a PhD in Chem Eng, I hope you read chem reactive relationships better than you read my posts.
First, I am a long and have quite a considerable stake. I bought into the convertibles as an accredited investor. And.....I have averaged down considerably. So, I can confirm what I have always and consistently stated: I believe DC VAX L will ultimately be approved by all RAs including the FDA. If the other evaluative criteria result in what we now expect, whether or not the PFS endpoint will be achieved is of relatively minor importance(I can't say no importance because it is, after all, a primary endpoint).
However, where the share price is concerned, that depends upon market forces and how the market perceives the trial results. In this case, not regulatory approval, technical failure by failing to meet primary/secondary endpoints will be focused upon by manipulators having a malevolent agenda. They will claim the trial failed. They will claim that approval is in jeopardy. And as you know, Wall Street just hates uncertainty.
Accordingly, it seems quite likely, to me at least, that the share price may be negatively impacted if that is the case. It certainly is a fair possibility and I think that LP is well aware of it. That is why she is pulling out all the stops to try and avoid such a scenario. After all, financing will no doubt depend upon it. We don't want to go through more cycles of toxic financings and debilitative dilutions due to a low stock price. Thus, in such a case, it is important that the endpoints are met. These when coupled with long tail and milestones, etc. will go a long way to ensure reasonable and sustainable share appreciation. There, not so bad is it, my friend Marzan?
Please re-read my posts on this subject several times for a complete understanding. If you are having any difficulties in comprehending my english, please don't be shy or embarrassed. Don't hesitate to ask. I will be pleased to assist you and relieve you of your confoundment. There, you see, you have something in common with PFS after all!
OK, Marzan, hope we are now on the same page. Still friends? LOL.
Your pal,
Umibe(not Umibie--no such word in Japanese)
Recent NWBO News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM